Etomidate for critically ill patients. Pro: yes we can use it

Area of Science:

• Critical Care Medicine
• Anesthesiology
• Pharmacology

Background:

• Etomidate is widely used for anesthesia induction in critically ill patients across various settings.
• Concerns exist regarding etomidate's adrenal suppression and potential association with adverse outcomes, particularly in sepsis.
• Hypotension poses significant harm to critically ill patients, necessitating careful anesthetic agent selection.

Purpose of the Study:

• To review the evidence surrounding the use of etomidate in critically ill patients.
• To address the controversy regarding etomidate's adrenal suppression and its clinical impact.
• To evaluate the safety and efficacy of etomidate in the context of hemodynamic stability.

Main Methods:

• Literature review of studies investigating etomidate's effects on adrenal function and patient outcomes.
• Analysis of evidence concerning the association between etomidate and hypotension.
• Assessment of clinical data, considering patient severity of illness.

Main Results:

• Etomidate is associated with adrenal suppression, but its clinical significance remains uncertain.
• No convincing evidence demonstrates harm from etomidate, especially after adjusting for illness severity.
• The debate on etomidate's use is characterized by clinical equipoise among medical experts.

Conclusions:

• The clinical consequences of etomidate-induced adrenal suppression are not definitively established.
• Current evidence does not consistently support a link between etomidate and worse patient outcomes.
• Further research and careful consideration of patient factors are warranted in the ongoing discussion of etomidate's role in critical care.